| Year |
Title |
Altmetric |
| 2022
|
Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!.
Journal of Medical Virology.
94:1255-1256.
2022
|
|
| 2021
|
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor.
Cell & Bioscience.
11.
2021
|
|
| 2021
|
Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection.
PLoS Pathogens.
17.
2021
|
|
| 2021
|
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.
mBio.
12.
2021
|
|
| 2020
|
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.
2020
|
|
| 2020
|
Global health concerns stirred by emerging viral infections.
Journal of Medical Virology.
92:399-400.
2020
|
|
| 2020
|
Zika virus NS5 nuclear accumulation is protective of protein degradation and is required for viral RNA replication.
Virology.
541:124-135.
2020
|
|
| 2019
|
Functional characterization of apolipoproteins in the HCV life cycle.
Methods in Molecular Biology.
1911:235-246.
2019
|
|
| 2019
|
Human apolipoprotein e promotes hepatitis B virus infection and production.
PLoS Pathogens.
15.
2019
|
|
| 2018
|
Tet-inducible production of infectious zika virus from the full-length cdna clones of African-and Asian-lineage strains.
Viruses.
10.
2018
|
|
| 2018
|
Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.
Virology.
524:1-9.
2018
|
|
| 2018
|
Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.
Journal of Virology.
92.
2018
|
|
| 2017
|
Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission.
Journal of Virology.
91.
2017
|
|
| 2017
|
Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling.
Oncotarget.
8:96171-96183.
2017
|
|
| 2017
|
TIM-1 promotes hepatitis C virus cell attachment and infection.
Journal of Virology.
91.
2017
|
|
| 2016
|
Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.
The Journal of Microbiology.
54:451-458.
2016
|
|
| 2015
|
Oncogenic viruses and cancer.
Virologica Sinica.
30:83-84.
2015
|
|
| 2015
|
A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus.
Scientific Reports.
5.
2015
|
|
| 2015
|
Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Journal of Virology.
89:3846-3858.
2015
|
|
| 2015
|
The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection.
Journal of Virology.
89:6782-6791.
2015
|
|
| 2013
|
Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors.
PLoS One.
8.
2013
|
|
| 2013
|
Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.
Journal of Virology.
87:6866-6875.
2013
|
|
| 2013
|
Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting.
Molecular and Cellular Biology.
33:1016-1026.
2013
|
|
| 2013
|
Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules.
Virology.
435:472-484.
2013
|
|
| 2013
|
Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
Autophagy.
9:175-195.
2013
|
|
| 2012
|
Transient activation of the PI3K-AKT pathway by hepatitis C virusto enhance viral entry.
Journal of Biological Chemistry.
287:41922-41930.
2012
|
|
| 2012
|
cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus.
Journal of Virology.
86:8987-8997.
2012
|
|
| 2012
|
Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
Journal of Virology.
86:7256-7267.
2012
|
|
| 2012
|
Hepatitis C virus infects the endothelial cells of the blood-brain barrier.
Gastroenterology.
142:634-643.e6.
2012
|
|
| 2011
|
Recent advance in antiviral drugs for hepatitis C.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
36:1025-1036.
2011
|
|
| 2010
|
Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microrna cluster.
Hepatology.
52:1877-1887.
2010
|
|
| 2010
|
Hepatitis c virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.
PLoS One.
5:1-10.
2010
|
|
| 2010
|
The C-terminal α-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.
Journal of Virology.
84:11532-11541.
2010
|
|
| 2010
|
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles (Journal of Virology (2009) 83, 24 (12680-12691)).
Journal of Virology.
84:4864.
2010
|
|
| 2010
|
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.
Hepatology.
51:43-53.
2010
|
|
| 2009
|
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.
Journal of Virology.
83:12680-12691.
2009
|
|
| 2009
|
FGI-104: A broad-spectrum small molecule inhibitor of viral infection.
American Journal of Translational Research.
1:87-98.
2009
|
|
| 2009
|
Proteomics study of the hepatitis C virus replication complex..
Methods in Molecular Biology.
510:185-193.
2009
|
|
| 2008
|
Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.
Hepatology.
48:1396-1403.
2008
|
|
| 2008
|
Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.
Journal of Virological Methods.
148:161-165.
2008
|
|
| 2007
|
Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture.
Journal of Virology.
81:13783-13793.
2007
|
|
| 2007
|
Human serum amyloid A protein inhibits hepatitis C virus entry into cells.
Journal of Virology.
81:6128-6133.
2007
|
|
| 2007
|
Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
Journal of Virology.
81:1043-1047.
2007
|
|
| 2006
|
Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: Protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.
Journal of Virology.
80:7364-7374.
2006
|
|
| 2006
|
The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA.
Virus Research.
115:1-8.
2006
|
|
| 2005
|
Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
Journal of Virology.
79:13963-13973.
2005
|
|
| 2005
|
Heterologous RNA replication enhancer stimulates in vitro RNA synthesis and template-switching by the carmovirus, but not by the tombusvirus, RNA-dependent RNA polymerase: Implication for modular evolution of RNA viruses.
Virology.
341:107-121.
2005
|
|
| 2005
|
Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase.
Journal of Virology.
79:11607-11617.
2005
|
|
| 2005
|
Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase.
Journal of Virology.
79:8687-8697.
2005
|
|
| 2005
|
An in vitro model of hepatitis C virion production.
Proceedings of the National Academy of Sciences of USA.
102:2579-2583.
2005
|
|
| 2004
|
Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS.
Clinical and Vaccine Immunology.
11:792-794.
2004
|
|
| 2004
|
Effects of Mutations of the Initiation Nucleotides on Hepatitis C Virus RNA Replication in the Cell.
Journal of Virology.
78:3633-3643.
2004
|
|
| 2004
|
Orally Active Fusion Inhibitor of Respiratory Syncytial Virus.
Antimicrobial Agents and Chemotherapy.
48:413-422.
2004
|
|
| 2003
|
Heterocyclic aminopyrrolidine derivatives as melatoninergic agents..
Bioorganic and Medicinal Chemistry Letters.
13:4381-4384.
2003
|
|
| 2003
|
Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA.
Journal of General Virology.
84:2761-2769.
2003
|
|
| 2003
|
Role of the 5′-proximal stem-loop structure of the 5′ untranslated region in replication and translation of hepatitis C virus RNA.
Journal of Virology.
77:3312-3318.
2003
|
|
| 2003
|
Retrospective analysis of non-A-E hepatitis: Possible role of hepatitis B and C virus infection.
Journal of Medical Virology.
69:59-65.
2003
|
|
| 2002
|
Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine.
Bioorganic and Medicinal Chemistry Letters.
12:3379-3382.
2002
|
|
| 2001
|
An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology.
Bioorganic and Medicinal Chemistry Letters.
11:2393-2396.
2001
|
|
| 2000
|
Salicylamide inhibitors of influenza virus fusion.
Bioorganic and Medicinal Chemistry Letters.
10:1649-1652.
2000
|
|
| 2000
|
De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus.
Journal of Virology.
74:851-863.
2000
|
|
| 1999
|
Novel quinolizidine salicylamide influenza fusion inhibitors.
Bioorganic and Medicinal Chemistry Letters.
9:2177-2180.
1999
|
|
| 1999
|
Conquering influenza: Recent advances in anti-influenza drug discovery.
IDrugs: the Investigational Drugs Journal.
2:671-685.
1999
|
|
| 1999
|
Cellular proteins bind to the poly(U) tract of the 3' untranslated region of hepatitis C virus RNA genome.
Virology.
256:105-118.
1999
|
|
| 1999
|
pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.
Journal of Virology.
73:1785-1794.
1999
|
|
| 1997
|
Inhibition of influenza viral polymerases by minimal viral RNA decoys.
Journal of General Virology.
78:2329-2333.
1997
|
|
| 1997
|
Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.
Journal of Virology.
71:4062-4070.
1997
|
|
| 1996
|
Characterization of a hemagglutinin-specific inhibitor of influenza A virus.
Virology.
226:66-76.
1996
|
|
| 1996
|
Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
Journal of Virology.
70:4246-4252.
1996
|
|
| 1995
|
Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: Identification of a novel inhibitor of influenza virus.
Antimicrobial Agents and Chemotherapy.
39:2204-2209.
1995
|
|
| 1994
|
Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation.
Journal of Virology.
68:5748-5754.
1994
|
|
| 1993
|
Erratum: Alterations of the stalk of the influenza virus neuraminidase: Deletions and insertions (Virus Research, 29/2, pp. 141-153 (1993)).
Virus Research.
29:321.
1993
|
|
| 1992
|
Genetic analysis of influenza virus.
Current Opinion in Genetics and Development.
2:77-81.
1992
|
|
| 1992
|
Mechanism of attenuation of a chimeric influenza A/B transfectant virus.
Journal of Virology.
66:4679-4685.
1992
|
|
| 1991
|
The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.
Journal of Virology.
65:2861-2867.
1991
|
|
| 1990
|
A specific base transition occurs on replicating hepatitis delta virus RNA.
Journal of Virology.
64:1021-1027.
1990
|
|
| 1990
|
Specificities involved in the initiation of retroviral plus-strand DNA.
Journal of Virology.
64:592-597.
1990
|
|
| 1990
|
Template switching by reverse transcriptase during DNA synthesis.
Journal of Virology.
64:4321-4328.
1990
|
|
